These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 27504461

  • 1. Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.
    Kronbichler A, Saleem MA, Meijers B, Shin JI.
    J Immunol Res; 2016; 2016():2068691. PubMed ID: 27504461
    [Abstract] [Full Text] [Related]

  • 2. Serum suPAR in patients with FSGS: trash or treasure?
    Maas RJ, Deegens JK, Wetzels JF.
    Pediatr Nephrol; 2013 Jul; 28(7):1041-8. PubMed ID: 23515666
    [Abstract] [Full Text] [Related]

  • 3. Primary and Recurrent Focal Segmental Glomerulosclerosis Closely Link to Serum Soluble Urokinase-type Plasminogen Activator Receptor Levels.
    Jin J, Li YW, He Q.
    Transplant Proc; 2015 Jul; 47(6):1760-5. PubMed ID: 26293047
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.
    Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J.
    Nat Med; 2011 Jul 31; 17(8):952-60. PubMed ID: 21804539
    [Abstract] [Full Text] [Related]

  • 7. Soluble urokinase receptor and focal segmental glomerulosclerosis.
    Reiser J, Wei C, Tumlin J.
    Curr Opin Nephrol Hypertens; 2012 Jul 31; 21(4):428-32. PubMed ID: 22569341
    [Abstract] [Full Text] [Related]

  • 8. Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation.
    Staeck O, Slowinski T, Lieker I, Wu K, Rudolph B, Schmidt D, Brakemeier S, Neumayer HH, Wei C, Reiser J, Budde K, Halleck F, Khadzhynov D.
    Transplantation; 2015 Dec 31; 99(12):2593-7. PubMed ID: 26371597
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method.
    Winnicki W, Sunder-Plassmann G, Sengölge G, Handisurya A, Herkner H, Kornauth C, Bielesz B, Wagner L, Kikić Ž, Pajenda S, Reiter T, Schairer B, Schmidt A.
    Sci Rep; 2019 Sep 24; 9(1):13783. PubMed ID: 31551522
    [Abstract] [Full Text] [Related]

  • 10. Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification.
    Morath C, Wei C, Macher-Goeppinger S, Schwenger V, Zeier M, Reiser J.
    Am J Ther; 2013 Sep 24; 20(2):226-9. PubMed ID: 23466622
    [Abstract] [Full Text] [Related]

  • 11. suPAR and chronic kidney disease-a podocyte story.
    Zeier M, Reiser J.
    Pflugers Arch; 2017 Aug 24; 469(7-8):1017-1020. PubMed ID: 28689240
    [Abstract] [Full Text] [Related]

  • 12. Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes.
    Harel E, Shoji J, Abraham V, Miller L, Laszik ZG, King A, Dobi D, Szabo G, Hann B, Sarwal MM, Craik CS, Vincenti F.
    Transplantation; 2020 Jan 24; 104(1):54-60. PubMed ID: 31449183
    [Abstract] [Full Text] [Related]

  • 13. Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis.
    Harita Y, Ishizuka K, Tanego A, Sugawara N, Chikamoto H, Akioka Y, Tsurumi H, Miura K, Gotoh Y, Tsujita M, Yamamoto T, Horike K, Takeda A, Oka A, Igarashi T, Hattori M.
    Pediatr Nephrol; 2014 Sep 24; 29(9):1553-60. PubMed ID: 24705794
    [Abstract] [Full Text] [Related]

  • 14. Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?
    Schlöndorff D.
    Kidney Int; 2014 Mar 24; 85(3):499-501. PubMed ID: 24583981
    [Abstract] [Full Text] [Related]

  • 15. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.
    Huang J, Liu G, Zhang YM, Cui Z, Wang F, Liu XJ, Chu R, Zhao MH.
    BMC Med; 2014 May 20; 12():81. PubMed ID: 24884842
    [Abstract] [Full Text] [Related]

  • 16. Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy.
    Alachkar N, Wei C, Arend LJ, Jackson AM, Racusen LC, Fornoni A, Burke G, Rabb H, Kakkad K, Reiser J, Estrella MM.
    Transplantation; 2013 Oct 15; 96(7):649-56. PubMed ID: 23842190
    [Abstract] [Full Text] [Related]

  • 17. Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab.
    Alachkar N, Li J, Matar D, Vujjini V, Alasfar S, Tracy M, Reiser J, Wei C.
    BMC Nephrol; 2018 Dec 17; 19(1):361. PubMed ID: 30558559
    [Abstract] [Full Text] [Related]

  • 18. Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis.
    Huang J, Liu G, Zhang YM, Cui Z, Wang F, Liu XJ, Chu R, Chen Y, Zhao MH.
    Kidney Int; 2013 Aug 17; 84(2):366-72. PubMed ID: 23447064
    [Abstract] [Full Text] [Related]

  • 19. The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis.
    Meijers B, Maas RJ, Sprangers B, Claes K, Poesen R, Bammens B, Naesens M, Deegens JK, Dietrich R, Storr M, Wetzels JF, Evenepoel P, Kuypers D.
    Kidney Int; 2014 Mar 17; 85(3):636-40. PubMed ID: 24402090
    [Abstract] [Full Text] [Related]

  • 20. Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.
    Franco Palacios CR, Lieske JC, Wadei HM, Rule AD, Fervenza FC, Voskoboev N, Garovic VD, Zand L, Stegall MD, Cosio FG, Amer H.
    Transplantation; 2013 Aug 27; 96(4):394-9. PubMed ID: 23736353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.